Literature DB >> 2499362

The t(5;14) chromosomal translocation in a case of acute lymphocytic leukemia joins the interleukin-3 gene to the immunoglobulin heavy chain gene.

J C Grimaldi1, T C Meeker.   

Abstract

Chromosomal translocations have proven to be important markers of the genetic abnormalities central to the pathogenesis of cancer. By cloning chromosomal breakpoints one can identify activated proto-oncogenes. We have studied a case of B-lineage acute lymphocytic leukemia (ALL) that was associated with peripheral blood eosinophilia. The chromosomal translocation t(5;14) (q31;q32) from this sample was cloned and studied at the molecular level. This translocation joined the immunoglobulin heavy chain joining (Jh) region to the promotor region of the interleukin-3 (IL-3) gene in opposite transcriptional orientations. The data suggest that activation of the IL-3 gene by the enhancer of the immunoglobulin heavy chain gene may play a central role in the pathogenesis of this leukemia and the associated eosinophilia.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2499362

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  13 in total

1.  Cardiac disease in a case of precursor B acute lymphoblastic leukaemia with eosinophilia(ALL/Eo).

Authors:  Mehrnaz Asadi Gharabaghi; Pegah Aghajanzadeh; Ghazal Zahedi; Roghayyeh Borji; Leila Derakhskan; Roya Sattarzadeh; Ramezanali Sharaifian
Journal:  BMJ Case Rep       Date:  2012-01-20

Review 2.  The emerging complexity of gene fusions in cancer.

Authors:  Fredrik Mertens; Bertil Johansson; Thoas Fioretos; Felix Mitelman
Journal:  Nat Rev Cancer       Date:  2015-06       Impact factor: 60.716

3.  Linkage mapping of the human CSF2 and IL3 genes.

Authors:  E I Frolova; G M Dolganov; I A Mazo; D V Smirnov; P Copeland; C Stewart; S J O'Brien; M Dean
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-01       Impact factor: 11.205

4.  Pivotal role for the NFIL3/E4BP4 transcription factor in interleukin 3-mediated survival of pro-B lymphocytes.

Authors:  S Ikushima; T Inukai; T Inaba; S D Nimer; J L Cleveland; A T Look
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-18       Impact factor: 11.205

Review 5.  Why clinicians should be interested in interleukin-3.

Authors:  P Valent; K Geissler; C Sillaber; K Lechner; P Bettelheim
Journal:  Blut       Date:  1990-12

6.  Structure-function relationships of interleukin-3. An analysis based on the function and binding characteristics of a series of interspecies chimera of gibbon and murine interleukin-3.

Authors:  K Kaushansky; S G Shoemaker; V C Broudy; N L Lin; J V Matous; E M Alderman; J D Aghajanian; P J Szklut; R E VanDyke; M K Pearce
Journal:  J Clin Invest       Date:  1992-11       Impact factor: 14.808

7.  Order of human hematopoietic growth factor and receptor genes on the long arm of chromosome 5, as determined by fluorescence in situ hybridization.

Authors:  P M Kluck; J Wiegant; A K Raap; H Vrolijk; H J Tanke; R Willemze; J E Landegent
Journal:  Ann Hematol       Date:  1993-01       Impact factor: 3.673

8.  Characterization of the BCR promoter in Philadelphia chromosome-positive and -negative cell lines.

Authors:  N P Shah; O N Witte; C T Denny
Journal:  Mol Cell Biol       Date:  1991-04       Impact factor: 4.272

Review 9.  Hypereosinophilia in childhood acute lymphoblastic leukaemia at diagnosis: report of 2 cases and review of the literature.

Authors:  Rosanna Parasole; Fara Petruzziello; Antonia De Matteo; Giovanna Maisto; Luisa Castelli; Maria Elena Errico; Giuseppe Menna; Vincenzo Poggi
Journal:  Ital J Pediatr       Date:  2014-04-10       Impact factor: 2.638

10.  A new gene, BCM, on chromosome 16 is fused to the interleukin 2 gene by a t(4;16)(q26;p13) translocation in a malignant T cell lymphoma.

Authors:  Y Laâbi; M P Gras; F Carbonnel; J C Brouet; R Berger; C J Larsen; A Tsapis
Journal:  EMBO J       Date:  1992-11       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.